M.J. Quiroz Quiroga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
M.J. Quiroz Quiroga has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- A. Martínez Palmer
Department of Ophthalmology, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain; Ophthalmology Department, Consorci Mar Parc de Salut de Barcelona, Passeig Marítim, 25-29, 08003 Barcelona, Spain
1 shared publication - A. Matheu Fabra
Neuro-ophthalmology unit, Ophthalmology department, Consorci Mar Parc de Salut de Barcelona, Passeig Marítim, 25-29, 08003 Barcelona, Spain; Department of Ophthalmology, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
1 shared publication Alejandro Rojas
Facultad de Medicina Universidad Católica de Chile, Santiago, Chile
1 shared publicationAlvaro Daniel Vidal
Instituto Oncológico FALP, Providencia, Chile
1 shared publication- Ana Palazon-Cabanes
Department of Ophthalmology, General University Hospital Reina Sofia, 30003 Murcia, Spain
1 shared publication Andres Vega
Facultad de Medicina Universidad de Chile, Santiago, Chile
1 shared publication
Latest Publications
- 18 May 2023
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 46 (8) , 941-948
Discrimination of glaucomatous from non-glaucomatous optic neuropathy with swept-source optical coherence tomography
- 18 May 2023
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 46 (8) , 941-948
Discrimination of glaucomatous from non-glaucomatous optic neuropathy with swept-source optical coherence tomography
- 1 October 2021
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 44 (8) , 1249-1255
Amblyopia due a dentigerous cyst. Case report and literature review
- 1 October 2021
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 44 (8) , 1249-1255
Amblyopia due a dentigerous cyst. Case report and literature review
- 1 December 2020
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 43 (10) , 1105-1106
A child with bilateral iris cysts: Iris Flocculi
- 1 December 2020
- Published by Elsevier in Journal Français d'Ophtalmologie
- Vol. 43 (10) , 1105-1106
A child with bilateral iris cysts: Iris Flocculi
- Open Access
- 10 January 2016
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 34 (2_suppl) , 155
Diagnostic capability of multiparametric MRI in patients with transrectal prostate biopsy.
155 Background: The prostatic multiparametric MRI (mpMRI) is the combination of anatomical imaging and functional sequences. Nowadays this technique is still being researched due to its positive published results. The objective of this study is to show our experience in the application of the mpMRI in patients, prior to the TRUS-guided biopsy, and the sensitivity and specificity of its measured parameters and their combination. Methods: Prospective cohort. MpMRI was indicated to patients prior to the TRUS-Guided biopsy. Diffusion, PIRADS, DCE and T2 parameters were observed on the MRIs, and the presence of cancer and Gleason score on the biopsy. Logistic regression test was performed with a 95% confidence interval. We assigned different values, depending of the importance of each factor, applying binominal regression. Results: We registered 73 patients with mpMRI prior to the TRUS-Guided Biopsy, and their results. The cancer detection rate was 60.27% (44 patients). The T2 signal had a sensibility of 81.82% and a specificity of 27.59%, ROC curve 0.54 (CI 0.44 – 0.64). The diffusion has a sensibility of 30% and a specificity of 85.19% with a ROC curve of 0.58 (CI 0.48-0.68). The DCE has a sensibility and specificity of 77.78% and 35.29% respectively, ROC curve of 0.57 (CI 0.42-0.71). By combining the T2, diffusion and DCE parameters, having 2 or more altered values, we obtained a sensibility of 84.62% with a 41.18% specificity, curve of 0.68 (CI 0.54-0.81). The sensitivity and specificity with a PIRADS score ≥ 3 was of 68.42 and 36.36% with a ROC curve of 0.56 (CI 0.36-0.76). With a PIRADS ≥ 4 the sensitivity and specificity was 57.89% and 54.55% respectively. The calculated measured score was assigned as 7 points for altered T2, 8 points for altered diffusion and 5 points for altered DCE. With a total value ≥ 12 the sensitivity of the score was 84.62% with a 41.18% sensitivity, ROC curve 0.68 (CI 0.54-0.81). Conclusions: The use of isolated mpMRI parameters have low performance, whereas this is greatly increased when used combined. The assigned weight of each parameter is a factor to consider and review on the existing scores.
- 10 January 2016
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 34 (2_suppl) , 155
Open AccessDiagnostic capability of multiparametric MRI in patients with transrectal prostate biopsy.
155 Background: The prostatic multiparametric MRI (mpMRI) is the combination of anatomical imaging and functional sequences. Nowadays this technique is still being researched due to its positive published results. The objective of this study is to show our experience in the application of the mpMRI in patients, prior to the TRUS-guided biopsy, and the sensitivity and specificity of its measured parameters and their combination. Methods: Prospective cohort. MpMRI was indicated to patients prior to the TRUS-Guided biopsy. Diffusion, PIRADS, DCE and T2 parameters were observed on the MRIs, and the presence of cancer and Gleason score on the biopsy. Logistic regression test was performed with a 95% confidence interval. We assigned different values, depending of the importance of each factor, applying binominal regression. Results: We registered 73 patients with mpMRI prior to the TRUS-Guided Biopsy, and their results. The cancer detection rate was 60.27% (44 patients). The T2 signal had a sensibility of 81.82% and a specificity of 27.59%, ROC curve 0.54 (CI 0.44 – 0.64). The diffusion has a sensibility of 30% and a specificity of 85.19% with a ROC curve of 0.58 (CI 0.48-0.68). The DCE has a sensibility and specificity of 77.78% and 35.29% respectively, ROC curve of 0.57 (CI 0.42-0.71). By combining the T2, diffusion and DCE parameters, having 2 or more altered values, we obtained a sensibility of 84.62% with a 41.18% specificity, curve of 0.68 (CI 0.54-0.81). The sensitivity and specificity with a PIRADS score ≥ 3 was of 68.42 and 36.36% with a ROC curve of 0.56 (CI 0.36-0.76). With a PIRADS ≥ 4 the sensitivity and specificity was 57.89% and 54.55% respectively. The calculated measured score was assigned as 7 points for altered T2, 8 points for altered diffusion and 5 points for altered DCE. With a total value ≥ 12 the sensitivity of the score was 84.62% with a 41.18% sensitivity, ROC curve 0.68 (CI 0.54-0.81). Conclusions: The use of isolated mpMRI parameters have low performance, whereas this is greatly increased when used combined. The assigned weight of each parameter is a factor to consider and review on the existing scores.